Revive Therapeutics proposes issuing 1,221,516 shares at $0.05 to settle $61,061 debt
- Revive Therapeutics proposed settling trade payables of $61,061 by issuing up to 1,221,516 common shares.
- Settlement shares priced at $0.05 each; creditors described as arm’s length.
- Closing expected no earlier than five business days; subject to Canadian Securities Exchange acceptance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revive Therapeutics Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608191435ACCESSWRNAPR_____1209358) on August 19, 2026, and is solely responsible for the information contained therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now